Toxicity and Efficacy of Busulfan and Fludarabine Myeloablative Conditioning for HLA-identical Sibling Allogeneic Hematopoietic Cell Transplantation in AML and MDS

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2016.42
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Myeloablative Doses of Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation in Non-Hodgkin'S Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Long-Term Results of Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-Intensity Conditioning With Busulfan, Fludarabine, and Antithymocyte Globulin

Neoplasma
Cancer Research
2011English

Fludarabine and Busulfan Versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Survival Advantage for Patients With AML and MDS Given Allogeneic Hematopoietic STEM CELL Transplantation Using Myeloablative Versus Reduced Intensity Conditioning (RIC) MAY Become Apparent 5-10 YEARS After Transplantation

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Reduced Toxicity Conditioning With Busulfan, Fludarabine, Alemtuzumab and Allogeneic Stem Cell Transplantation From HLA-Matched Sibling Donors in Children With High Risk Sickle Cell Disease Results in Long Term Donor Chimerism and Low Incidence of aGVHD

Biology of Blood and Marrow Transplantation
TransplantationHematology
2013English

Missing HLA C Group 1 Ligand in Patients With AML and MDS Is Associated With Reduced Risk of Relapse and Better Survival After Allogeneic Stem Cell Transplantation With Fludarabine and Treosulfan Reduced Toxicity Conditioning

American Journal of Hematology
Hematology
2017English

Busulfan Fludarabine vs Busulfan Cyclophosphamide as a Preparative Regimen Before Allogeneic Hematopoietic Cell Transplantation: Systematic Review and Meta-Analysis

Bone Marrow Transplantation
TransplantationHematology
2015English

The Dilemma of Conditioning Intensity: When Does Myeloablative Conditioning Improve Outcomes for Allogeneic Hematopoietic Cell Transplantation?

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy